Structures by: Frehland B.
Total: 4
C19H21NO3
C19H21NO3
Organic & biomolecular chemistry (2014) 12, 29 5407-5426
a=12.5520(10)Å b=8.4900(10)Å c=15.7250(10)Å
α=90.00° β=104.140(10)° γ=90.00°
(1<i>S</i>*,2<i>R</i>*)-7-Methoxy-2-methyl-3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepin-1-ol
C22H29NO2
Acta Crystallographica Section E (2016) 72, 5 687-691
a=10.3594(2)Å b=18.8246(4)Å c=10.9981(3)Å
α=90.00° β=117.8890(10)° γ=90.00°
(1<i>R</i>*,2<i>R</i>*)-7-Methoxy-2-methyl-3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepin-1-ol
C22H29NO2
Acta Crystallographica Section E (2016) 72, 5 687-691
a=9.2049(5)Å b=25.4468(17)Å c=8.2451(6)Å
α=90.00° β=90.00° γ=90.00°
(1<i>S</i>*,2<i>R</i>*)-7-Benzyloxy-2-methyl-3-tosyl-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepin-1-ol
C25H27NO4S
Acta Crystallographica Section E (2016) 72, 5 683-686
a=7.5071(2)Å b=23.6113(8)Å c=24.5180(8)Å
α=90.00° β=90.00° γ=90.00°